The latest closing stock price for Actuate Therapeutics as of February 21, 2025 is 7.69.
An investor who bought $1,000 worth of Actuate Therapeutics stock at the IPO in 2024 would have $-107 today, roughly 0 times their original investment - a -10.69% compound annual growth rate over 1 years.
The all-time high Actuate Therapeutics stock closing price was 11.00 on January 23, 2025.
The Actuate Therapeutics 52-week high stock price is 11.73, which is 52.5% above the current share price.
The Actuate Therapeutics 52-week low stock price is 5.51, which is 28.3% below the current share price.
The average Actuate Therapeutics stock price for the last 52 weeks is 8.22.
An investor who bought $1,000 worth of Actuate Therapeutics stock at the IPO in 2024 would have $-107 today, roughly 0 times their original investment - a -10.69% compound annual growth rate over 1 years.
The all-time high Actuate Therapeutics stock closing price was 11.00 on January 23, 2025.
The Actuate Therapeutics 52-week high stock price is 11.73, which is 52.5% above the current share price.
The Actuate Therapeutics 52-week low stock price is 5.51, which is 28.3% below the current share price.
The average Actuate Therapeutics stock price for the last 52 weeks is 8.22.